Health IT Startups with sights set on the Triple Aim, an Ohio health IT group has a contest for you By
MedCity Influencers, Health Tech This Winter, Data Is Armor Against “Tripledemic” Healthcare Challenges By Kate Behan
BioPharma, Pharma GSK Patent Suit Aims to Halt Pfizer’s RSV Vaccine for Adults, But Not Infants By Frank Vinluan
BioPharma, Pharma Gilead claims breast cancer trial win but offers few details; drug application is filed with FDA By Frank Vinluan
Diagnostics, Hospitals Thermo Fisher aims to make next-gen sequencing more accessible to community hospitals By Alaric DeArment
BioPharma, Policy FDA expert panel gives thumbs-up to Aimmune’s peanut allergy drug By Alaric DeArment
Telemedicine, Startups UPMC Enterprises-backed Curavi acquires telemedicine business TripleCare By Erin Dietsche
Diagnostics, Pharma Next-generation sequencing market to nearly triple in size by 2024, report says By Alaric DeArment
Daily Morning Read: GSK CEO warns of big pharma shakeup, Valeant management will confront ‘pharmaceutical Enron’ claims By Stephanie Baum
Health IT, Devices & Diagnostics Cerner tool said to triple accuracy of fall-risk assessment By Neil Versel
Daily E-cigarette use in teens has tripled; should Dr. Oz go from Columbia University? (Morning Read) By Nicole Oran
Devices & Diagnostics Healthcare companies repay feds in False Claims Act settlements By MassDevice Staff
